Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Daniel Duerschmied and Jonathan Rilinger.
Daniel Duerschmied
Connection Strength
0.337
Jonathan Rilinger
  1. A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jun 03; 21(1):470.
    View in: PubMed
    Score: 0.221
  2. Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation: protocol for a randomised, controlled, open-label intervention, multicentre trial. BMJ Open. 2021 01 17; 11(1):e043345.
    View in: PubMed
    Score: 0.058
  3. Outcome of acute respiratory distress syndrome requiring extracorporeal membrane oxygenation in Covid-19 or influenza: A single-center registry study. Artif Organs. 2021 Jun; 45(6):593-601.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.